Cancer Research Versailles No Abst  Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4890-4897, October 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrita, M. A.
Right arrow Articles by Cass, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrita, M. A.
Right arrow Articles by Cass, C. E.
[Cancer Research 59, 4890-4897, October 1, 1999]
© 1999 American Association for Cancer Research


Experimental Therapeutics

Mouse Transporter Protein, a Membrane Protein That Regulates Cellular Multidrug Resistance, Is Localized to Lysosomes1

Miguel A. Cabrita, Tom C. Hobman, Douglas L. Hogue, Karen M. King and Carol E. Cass2

MRC Molecular Biology of Membranes Group [M. A. C., K. M. K., C. E. C.] and Departments of Biochemistry [M. A. C., K. M. K., C. E. C.], Cell Biology [T. C. H.], and Oncology [C. E. C.], University of Alberta, and Cross Cancer Institute [M. A. C., K. M. K., C. E. C.], Edmonton, Alberta T6G 1Z2, Canada, and British Columbia Cancer Research Centre, Vancouver, British Columbia V5Z 1L3, Canada [D. L. H.]

Mouse transporter protein (MTP), a small, highly conserved mammalian intracellular membrane protein with four putative transmembrane domains, has been implicated in the transport of nucleosides and/or related molecules across intracellular membranes. The production of recombinant MTP in Saccharomyces cerevisiae alters sensitivity of yeast cells to a heterogeneous group of compounds (e.g., antimetabolites, antibiotics, anthracyclines, ionophores, and steroid hormones) by changing the subcellular compartmentalization of these drugs, suggesting that MTP functions similarly in higher organisms. The present study was undertaken to define the intracellular location of MTP in mammalian cells. Native MTP was not detected by indirect immunofluorescence in cell types that expressed MTP mRNA; therefore, a hemagglutinin (HA) epitope-tagged version of MTP was produced in cultured BHK21 cells by transient transfection, and its distribution within cells was determined by confocal microscopy using antibodies directed against the HA epitope and various organellar proteins. Antibodies directed against HA-MTP colocalized with antibodies against late endosomal and lysosomal proteins but not with antibodies against either Golgi or early endosomal proteins. Analysis of subcellular fractions from rat liver by immunoblotting with antibodies directed against MTP demonstrated the presence of a MTP-like protein in Golgi- and lysosome-enriched membranes but not in mitochondria. These results indicate that MTP resides in late endosomes and lysosomes, a finding that is consistent with the proposed role for MTP in the movement of a variety of small molecules across endosomal and lysosomal membranes. MTP shares a number of characteristics with other lysosome-associated proteins. We, therefore, propose that it be redesignated murine lysosome-associated protein transmembrane 4.




This article has been cited by other articles:


Home page
Ann OncolHome page
X.-J. Cheng, W. Xu, Q.-Y. Zhang, and R.-L. Zhou
Relationship between LAPTM4B gene polymorphism and susceptibility of colorectal and esophageal cancers
Ann. Onc., March 1, 2008; 19(3): 527 - 532.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
Y Liu, Q-Y Zhang, N Qian, and R-L Zhou
Relationship between LAPTM4B gene polymorphism and susceptibility of gastric cancer
Ann. Onc., February 1, 2007; 18(2): 311 - 316.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
Y. Pak, W. K. Glowacka, M. C. Bruce, N. Pham, and D. Rotin
Transport of LAPTM5 to lysosomes requires association with the ubiquitin ligase Nedd4, but not LAPTM5 ubiquitination
J. Cell Biol., November 20, 2006; 175(4): 631 - 645.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
F. Colland, X. Jacq, V. Trouplin, C. Mougin, C. Groizeleau, A. Hamburger, A. Meil, J. Wojcik, P. Legrain, and J.-M. Gauthier
Functional Proteomics Mapping of a Human Signaling Pathway
Genome Res., July 1, 2004; 14(7): 1324 - 1332.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Rajagopal and S. M. Simon
Subcellular Localization and Activity of Multidrug Resistance Proteins
Mol. Biol. Cell, August 1, 2003; 14(8): 3389 - 3399.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.